Antibody Engineering & Therapeutics Asia

Fusion Antibodies is pleased to be attending Antibody Engineering & Therapeutics Asia.

Taking place virtually on the 5-8th April 2021. Antibody Engineering & Therapeutics Asia is the only event in Asia providing the latest science, technology and partners to accelerate Antibody & protein therapies, ADCS, bispecifics and immuno-oncology.

Get in touch with our team at and organise a meeting with our Director of Business Development Brett Whitecross to learn more about how we can help with drug discovery and development projects.

We look forward to meeting you!